Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 4257498, 11 pages
http://dx.doi.org/10.1155/2016/4257498
Research Article

The Coadministration of N-Acetylcysteine Ameliorates the Effects of Arsenic Trioxide on the Male Mouse Genital System

1Department of Morphology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), 18618-970 Botucatu, SP, Brazil
2Department of Pharmacology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), 18618-970 Botucatu, SP, Brazil
3Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences, University of São Paulo (USP), 14040-903 Ribeirão Preto, SP, Brazil
4Department of Morphology, Stomatology, and Physiology, School of Dentistry, University of São Paulo (USP), 14040-903 Ribeirão Preto, SP, Brazil

Received 4 May 2015; Accepted 30 September 2015

Academic Editor: Joseph A. Adeyemi

Copyright © 2016 Raquel Frenedoso da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. K. Mandal and K. T. Suzuki, “Arsenic round the world: a review,” Talanta, vol. 58, no. 1, pp. 201–235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. Ratnaike, “Acute and chronic arsenic toxicity,” Postgraduate Medical Journal, vol. 79, no. 933, pp. 391–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G.-Q. S. Chen, X.-G. Shi, W. Tang et al., “Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells,” Blood, vol. 89, no. 9, pp. 3345–3353, 1997. View at Google Scholar · View at Scopus
  4. S. L. Soignet, P. Maslak, Z.-G. Wang et al., “Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide,” The New England Journal of Medicine, vol. 339, no. 19, pp. 1341–1348, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Soignet, S. R. Frankel, D. Douer et al., “United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia,” Journal of Clinical Oncology, vol. 19, no. 18, pp. 3852–3860, 2001. View at Google Scholar · View at Scopus
  6. V. Mathews, B. George, K. M. Lakshmi et al., “Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity,” Blood, vol. 107, no. 7, pp. 2627–2632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Mathews, E. Chendamarai, B. George, A. Viswabandya, and A. Srivastava, “Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 3, no. 1, Article ID e2011056, 2011. View at Publisher · View at Google Scholar
  8. J. Lin, H. Zhu, S. Li, H. Fan, and X. Lu, “Complete remission of acute promyelocytic leukemia in a very elderly patient after treatment with low dose arsenic trioxide and sequential retinoic acid: a case report,” Annals of Hematology, vol. 93, no. 2, pp. 335–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. H. K. Lorenzo, S. A. Susin, J. Penninger, and G. Kroemer, “Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death,” Cell Death and Differentiation, vol. 6, no. 6, pp. 516–524, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-J. Chiou, S.-T. Chu, W.-F. Tzeng, Y.-C. Huang, and C. Liao Jr., “Arsenic trioxide impairs spermatogenesis via reducing gene expression levels in testosterone synthesis pathway,” Chemical Research in Toxicology, vol. 21, no. 8, pp. 1562–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-J. Kim, J.-Y. Chung, S. G. Lee et al., “Arsenic trioxide-induced apoptosis in TM4 Sertoli cells: the potential involvement of p21 expression and p53 phosphorylation,” Toxicology, vol. 285, no. 3, pp. 142–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Cobo and M. Castiñeira, “Oxidative stress, mitochondrial respiration, and glycemic control: clues from chronic supplementation with Cr3+ or As3+ to male Wistar rats,” Nutrition, vol. 13, no. 11-12, pp. 965–970, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” The FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. R. França, G. F. Avelar, and F. F. L. Almeida, “Spermatogenesis and sperm transit through the epididymis in mammals with emphasis on pigs,” Theriogenology, vol. 63, no. 2, pp. 300–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. W. Robb, R. P. Amann, and G. J. Killian, “Daily sperm production and epididymal sperm reserves of pubertal and adult rats,” Journal of Reproduction and Fertility, vol. 54, no. 1, pp. 103–107, 1978. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Sablina, A. V. Budanov, G. V. Ilyinskaya, L. S. Agapova, J. E. Kravchenko, and P. M. Chumakov, “The antioxidant function of the p53 tumor suppressor,” Nature Medicine, vol. 11, no. 12, pp. 1306–1313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Atorino, S. Di Meglio, B. Farina, R. Jones, and P. Quesada, “Rat germinal cells require PARP for repair of DNA damage induced by gamma-irradiation and H2O2 treatment,” European Journal of Cell Biology, vol. 80, no. 3, pp. 222–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Nava-Hernandez, L. A. Hauad-Marroquin, S. Bassol-Mayagoitia et al., “Lead-, cadmium-, and arsenic-induced DNA damage in rat germinal cells,” DNA and Cell Biology, vol. 28, no. 5, pp. 241–248, 2009. View at Publisher · View at Google Scholar
  19. I. Mangelsdorf, J. Buschmann, and B. Orthen, “Some aspects relating to the evaluation of the effects of chemicals on male fertility,” Regulatory Toxicology and Pharmacology, vol. 37, no. 3, pp. 356–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Benedetti, M. C. Tagliamonte, S. Catalani et al., “Differences in blood and semen oxidative status in fertile and infertile men, and their relationship with sperm quality,” Reproductive BioMedicine Online, vol. 25, no. 3, pp. 300–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Emadi and S. D. Gore, “Arsenic trioxide—an old drug rediscovered,” Blood Reviews, vol. 24, no. 4-5, pp. 191–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. D. Clegg, S. D. Perreault, and G. R. Klinefelter, “Assessment of male reproductive toxicity,” in Principles and Methods of Toxicology, A. W. Hayes, Ed., pp. 1263–1300, Taylor & Francis, Philadelphia, Pa, USA, 2001. View at Google Scholar
  23. S. W. Hayward, L. S. Baskin, P. C. Haughney et al., “Stromal development in the ventral prostate, anterior prostate and seminal vesicle of the rat,” Acta Anatomica, vol. 155, no. 2, pp. 94–103, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Maines and R. D. Mayer, “Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis by cis-platinum. Reversal by human chorionic gonadotropin,” The Journal of Biological Chemistry, vol. 260, no. 10, pp. 6063–6068, 1985. View at Google Scholar · View at Scopus
  25. B. L. Batista, J. M. O. Souza, S. S. De Souza, and F. Barbosa Jr., “Speciation of arsenic in rice and estimation of daily intake of different arsenic species by Brazilians through rice consumption,” Journal of Hazardous Materials, vol. 191, no. 1–3, pp. 342–348, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Bhattacharya, G. Jacks, K. M. Ahmed, J. Routh, and A. A. Khan, “Arsenic in groundwater of the Bengal Delta Plain aquifers in Bangladesh,” Bulletin of Environmental Contamination and Toxicology, vol. 69, no. 4, pp. 538–545, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. H. V. Aposhian, “Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity,” Annual Review of Pharmacology and Toxicology, vol. 37, pp. 397–419, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Chen, X. Jiang, Y. Lai, Y. Liu, and Z. Zhang, “Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression,” Environmental and Molecular Mutagenesis, vol. 56, no. 3, pp. 333–346, 2015. View at Publisher · View at Google Scholar
  29. Z. Zhang, L. Gao, Y. Cheng et al., “Resveratrol, a natural antioxidant, has a protective effect on liver injury induced by inorganic arsenic exposure,” BioMed Research International, vol. 2014, Article ID 617202, 7 pages, 2014. View at Publisher · View at Google Scholar
  30. W. Zhao, Y.-N. Hu, X.-J. Jiang, C.-Z. Chen, and Z.-Z. Zhang, “The apoptotic mechanism of hepatocellular carcinoma cell line (HepG2) induced by arsenic trioxide,” Journal of Sichuan University: Medical Science Edition, vol. 45, no. 5, pp. 739–743, 2014. View at Google Scholar · View at Scopus
  31. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  32. Y. J. Suzuki, H. J. Forman, and A. Sevanian, “Oxidants as stimulators of signal transduction,” Free Radical Biology & Medicine, vol. 22, no. 1-2, pp. 269–285, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zheng, H. Yamaguchi, C. Tian et al., “Arsenic trioxide (As2O3) induces apoptosis through activation of Bax in hematopoietic cells,” Oncogene, vol. 24, no. 20, pp. 3339–3347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Yi, F. Gao, G. Shi et al., “The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide,” Apoptosis, vol. 7, no. 3, pp. 209–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Gao, J. Yi, J. Q. Yuan, G. Y. Shi, and X. M. Tang, “The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species,” Cell Research, vol. 14, no. 1, pp. 81–85, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. J. S. Flora, “Arsenic-induced oxidative stress and its reversibility,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 257–281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Vendemiale, I. Grattagliano, and E. Altomare, “An update on the role of free radicals and antioxidant defense in human disease,” International Journal of Clinical & Laboratory Research, vol. 29, no. 2, pp. 49–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Jomova, Z. Jenisova, M. Feszterova et al., “Arsenic: toxicity, oxidative stress and human disease,” Journal of Applied Toxicology, vol. 31, no. 2, pp. 95–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Greaves, Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation, Elsevier Science, Amsterdam, The Netherlands, 2000.
  40. D. Kotyzová, M. Bludovská, and V. Eybl, “Differential influences of various arsenic compounds on antioxidant defense system in liver and kidney of rats,” Environmental Toxicology and Pharmacology, vol. 36, no. 3, pp. 1015–1021, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Modi, R. K. Kaul, G. M. Kannan, and S. J. S. Flora, “Co-administration of zinc and n-acetylcysteine prevents arsenic-induced tissue oxidative stress in male rats,” Journal of Trace Elements in Medicine and Biology, vol. 20, no. 3, pp. 197–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Santra, A. Chowdhury, S. Ghatak, A. Biswas, and G. K. Dhali, “Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine,” Toxicology and Applied Pharmacology, vol. 220, no. 2, pp. 146–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. P. S. Reddy, G. P. Rani, S. B. Sainath, R. Meena, and C. Supriya, “Protective effects of N-acetylcysteine against arsenic-induced oxidative stress and reprotoxicity in male mice,” Journal of Trace Elements in Medicine and Biology, vol. 25, no. 4, pp. 247–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Fan, M. Chen, J. Meng et al., “Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity,” PLoS ONE, vol. 9, no. 8, Article ID e105890, 2014. View at Publisher · View at Google Scholar
  45. F. F. Bellentani, G. S. A. Fernandes, J. E. Perobelli et al., “Acceleration of sperm transit time and reduction of sperm reserves in the epididymis of rats exposed to sibutramine,” Journal of Andrology, vol. 32, no. 6, pp. 718–724, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A.-M. Florea and D. Büsselberg, “Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells,” Toxicology Letters, vol. 179, no. 1, pp. 34–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. S. Borges, G. Missassi, E. S. A. Pacini et al., “Slimmer or fertile? Pharmacological mechanisms involved in reduced sperm quality and fertility in rats exposed to the anorexigen sibutramine,” PLoS ONE, vol. 8, no. 6, Article ID e66091, 2013. View at Publisher · View at Google Scholar · View at Scopus